Drug & medication recalls Moderate risk

EPINEPHIrine in 0 recalled over sterility concerns

Recall date
November 12, 2021
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
SterRx, LLC recalls EPINEPHIrine in 0.9% Sodium Chloride Injection, 5 mg per 250 mL (20 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Platt…
Recall number
D-0309-2022
FDA classification
Class II
Brand / firm
SterRx, LLC
Sold / distributed
U.S.A. Nationwide

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

EPINEPHIrine in 0.9% Sodium Chloride Injection, 5 mg per 250 mL (20 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-052-01.

Get recall alerts

Free email alert whenever SterRx, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: SterRx, LLC